Sol-Gel Technologies Ltd. Share Price & Technical Analysis
SLGL · $76.73 (+12.33%)
Healthcare / Biotechnology
$76.73
+12.33%
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatm…
Price chart
Seasonality
May has 4 positive and 1 negative years (last 5 years shown)
2% return in May, 5% avg return in past 3 year May month.
74% return in 2026, 42% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 47% | 45% | -13% | -7% | 2% | – | – | – | – | – | – | – | 74% |
| 25 | -19% | -14% | -22% | 46% | 3% | 3% | 73% | 85% | 22% | 14% | 23% | 0% | 213% |
| 24 | 28% | -25% | -15% | -29% | 13% | 14% | -53% | 63% | 0% | -30% | 8% | 66% | 40% |
| 23 | 10% | -15% | -17% | -8% | 0% | -17% | 27% | -31% | -39% | -20% | 1% | -17% | -125% |
| 22 | -7% | 12% | -1% | -6% | -16% | -31% | 38% | 11% | -17% | -8% | -6% | 1% | -30% |
Monthly return % by calendar month · historical pattern, not a forecast
Bullish · Uptrend · Uptrend
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat olmsted syndrome. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$221.75M
P/E ratio
—
52W high
$97.97
52W low
$6.80
Volume
76,601
Beta
1.17
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Sol-Gel Technologies Ltd. share price today?
- Sol-Gel Technologies Ltd. (SLGL) last traded around $76.73 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does SLGL have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for SLGL. Download the app for real-time alerts.
- How can I analyze Sol-Gel Technologies Ltd. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.